GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Acer Medical Inc (ROCO:6857) » Definitions » EV-to-EBITDA

Acer Medical (ROCO:6857) EV-to-EBITDA : -64.78 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Acer Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Acer Medical's enterprise value is NT$2,581.56 Mil. Acer Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-39.85 Mil. Therefore, Acer Medical's EV-to-EBITDA for today is -64.78.

The historical rank and industry rank for Acer Medical's EV-to-EBITDA or its related term are showing as below:

ROCO:6857' s EV-to-EBITDA Range Over the Past 10 Years
Min: -68.22   Med: -26.61   Max: -10.77
Current: -64.78

During the past 5 years, the highest EV-to-EBITDA of Acer Medical was -10.77. The lowest was -68.22. And the median was -26.61.

ROCO:6857's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 12.675 vs ROCO:6857: -64.78

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Acer Medical's stock price is NT$170.00. Acer Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.510. Therefore, Acer Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Acer Medical EV-to-EBITDA Historical Data

The historical data trend for Acer Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acer Medical EV-to-EBITDA Chart

Acer Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - - -15.32 -65.16

Acer Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - -15.32 - -65.16

Competitive Comparison of Acer Medical's EV-to-EBITDA

For the Health Information Services subindustry, Acer Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acer Medical's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Acer Medical's EV-to-EBITDA falls into.



Acer Medical EV-to-EBITDA Calculation

Acer Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2581.562/-39.852
=-64.78

Acer Medical's current Enterprise Value is NT$2,581.56 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acer Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-39.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acer Medical  (ROCO:6857) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Acer Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=170.00/-2.510
=At Loss

Acer Medical's share price for today is NT$170.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acer Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Acer Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Acer Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Acer Medical (ROCO:6857) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Rd, 7th Floor, No. 86, Section 1, Xizhi District, New Taipei, TWN
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and big data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions into medical institutions.

Acer Medical (ROCO:6857) Headlines

No Headlines